scholarly article | Q13442814 |
P356 | DOI | 10.1016/0024-3205(84)90563-0 |
P953 | full work available at URL | https://api.elsevier.com/content/article/PII:0024320584905630?httpAccept=text/xml |
https://api.elsevier.com/content/article/PII:0024320584905630?httpAccept=text/plain | ||
P698 | PubMed publication ID | 6092812 |
P2093 | author name string | I. S. Zagon | |
P. J. McLaughlin | |||
P2860 | cites work | Naltrexone reduces weight gain, alters "beta-endorphin", and reduces insulin output from pancreatic islets of genetically obese mice | Q38357225 |
Opiates, endorphins and the developing organism: A comprehensive bibliography | Q38583910 | ||
Enhanced analgesic effects of morphine after chronic administration of naloxone in the rat | Q40134620 | ||
Chronic naloxone results in prolonged increases in opiate binding sites in brain | Q40177996 | ||
Enkephalin-Containing Neurons Visualized in Spinal Cord Cell Cultures | Q40904838 | ||
Failure of β-endorphin antiserum, naloxone, and naltrexone to alter physiologic growth hormone and insulin secretion | Q41159516 | ||
Duration of opiate receptor blockade determines tumorigenic response in mice with neuroblastoma: a role for endogenous opioid systems in cancer | Q44351428 | ||
The effects of different schedules of methadone treatment on rat brain development | Q45158015 | ||
An opiate withdrawal-like phenomenon in the fetal guinea pig ileum upon naloxone challenge | Q46906843 | ||
Increased brain size and cellular content in infant rats treated with an opiate antagonist | Q47250074 | ||
Effect of Litter Size on Weight Gain in Rats | Q47339583 | ||
Effect of Severe Undernutrition in Early Life on Growth, Brain Size and Composition in Adult Rats | Q47402420 | ||
Inhibition by d,l-methadone of RNA and protein synthesis in neonatal mice: antagonism by naloxone or naltrexone | Q48192307 | ||
Effects of maternal dietary protein restriction on growth of the brain and body in the rat. | Q48308252 | ||
Ontogenetic development of [3H]naloxone binding in rat brain | Q48366271 | ||
Origin of brain growth retardation in young rats treated with phenobarbital | Q48399381 | ||
Naltrexone-induced opiate receptor supersensitivity | Q48911058 | ||
3HEtorphine binding activity in early chick embryos: Brain and body tissue | Q48951630 | ||
Undernutrition and cerebellar development | Q49061743 | ||
Prenatal Cerebral Development: Effect of Restricted Diet, Reversal by Growth Hormone | Q51116992 | ||
The effects of opiate antagonists on milk intake of preweanling rats. | Q52286966 | ||
Perinatal development of the endorphin- and enkephalin-containing systems in the rat brain. | Q52300789 | ||
Naltrexone modulates growth in infant rats | Q70176756 | ||
Naloxone prolongs the survival time of mice treated with neuroblastoma | Q70770672 | ||
Naltrexone modulates tumor response in mice with neuroblastoma | Q71778547 | ||
Methionine-enkephalin immunoreactivity in fetal rat brain cells in aggregating culture and in mouse neuroblastoma cells | Q72147935 | ||
Ontogenesis of enkephalinergic systems in rat brain: Post-natal changes in enkephalin levels, receptors and degrading enzyme activities | Q72859846 | ||
P433 | issue | 20 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | naltrexone | Q409587 |
opioid | Q427523 | ||
P304 | page(s) | 2057-2064 | |
P577 | publication date | 1984-11-01 | |
1984-11-12 | |||
P1433 | published in | Life Sciences | Q5256275 |
P1476 | title | Naltrexone modulates body and brain development in rats: A role for endogenous opioid systems in growth | |
P478 | volume | 35 |
Q34163501 | Brain opioids and autism: an updated analysis of possible linkages |
Q41083482 | Changes in microtubular tau protein after morphine in a cultured human neuroblastoma cell line |
Q29547388 | Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models |
Q30395013 | Developmental consequences of fetal exposure to drugs: what we know and what we still must learn |
Q48767218 | Endogenous opioids regulate cell proliferation in the retina of developing rat |
Q41835138 | Knockout of the mu opioid receptor enhances the survival of adult-generated hippocampal granule cell neurons |
Q57073133 | Larger Numbers of Glial and Neuronal Cells in the Periaqueductal Gray Matter of μ-Opioid Receptor Knockout Mice |
Q68922150 | Localization of enkephalin immunoreactivity in diverse tissues and cells of the developing and adult rat |
Q28484561 | Maternally administered sustained-release naltrexone in rats affects offspring neurochemistry and behaviour in adulthood |
Q37999447 | Naltrexone in the treatment of opioid-dependent pregnant women: the case for a considered and measured approach to research |
Q48520664 | Naltrexone is not detected in preweaning rats following transplacental exposure: implications for growth modulation |
Q38724027 | Neuropeptides induce directional asymmetry in brain and spinal cord: facts and hypotheses |
Q33876802 | Opioid growth factor and organ development in rat and human embryos |
Q34213275 | Opioid growth factor modulation of corneal epithelium: uppers and downers |
Q43332529 | Opioid receptor blockade during prenatal life modifies postnatal behavioral development |
Q39965758 | Opioids and the developing organism: a comprehensive bibliography, 1984-1988. |
Q44349541 | Postnatal development of multiple opioid receptors in the spinal cord and development of spinal morphine analgesia |
Q48384028 | Preproenkephalin gene expression and [Met5]-enkephalin levels in the developing rat heart |
Q44349298 | Re-epithelialization of the rat cornea is accelerated by blockade of opioid receptors |
Q34585320 | Review article: the concept of entero-colonic encephalopathy, autism and opioid receptor ligands |
Q44340325 | Targeting the opioid growth factor: opioid growth factor receptor axis for treatment of human ovarian cancer |
Q30490602 | The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data. |
Q44126086 | Urinary peptides in Rett syndrome |